Anne Li April 23rd, 2017
Matching the size of a tumour to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread, according to a small US study. Researchers found that patients who didn’t respond to treatment had an imbalance between the size of their tumour and how exhausted their immune cells were. The study, published in the journal Nature, provides clues that could help doctors identify patients whose tumours aren’t responding to certain immunotherapy drugs sooner, and possibly explain why.
See original article at: http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-04-12-study-suggests-why-an-immunotherapy-drug-works-in-some-melanoma-patients-but-not-in-others